Navigation Links
TPO (Ab) RIA Thyroid Function 014-HD-90.1 Thyroid Peroxidase

ProductsTPO (Ab) RIA Thyroid Function 014-HD-90.1 Thyroid Peroxidase
Company ALPCO Diagnostics
Item TPO (Ab) RIA Thyroid Function 014-HD-90.1 Thyroid Peroxidase
Features 
Description DYNOtest anti-TPOn is a competitive radioimmunoassay for the quantitative determination of autoantibodies to thyroid peroxidase (TPO) in human serum using the coated tube technique. For the DYNOtest anti-TPOn BRAHMS employs exclusively enzymatic active native TPO from human thyroids. For the de- termination of anti-TPO antibodies older methods use as antigen denaturated resp. modified or recombinant TPO. In contrast to this the native structure of the antigen employed in the DYNO- test anti-TPOn guarantees the correct recognition of all classes and subclasses of antibodies, inclusive antibodies, which are directed only against the natural structure of the TPO. The anti- gen TPO used in this competitive assay is indirectly labelled with a monoclonal iodine-125 antibody to prevent the denaturation of the sensitive antigen. In connection with the monoclonal antibody on the solid phase this method guarantees a high sensitivity and specificity. During incubation, solid-phase monoclonal anti-TPO antibodies and enzymatic active native TPO from human thyroids form a complex with another iodine-125 labelled monoclonal anti-TPO antibody. Anti-TPO autoantibodies from a human serum sample or the standards compete with monoclonal anti-TPO antibodies immobilized on the inner surface of the tube for the binding sites on TPO. A high concentration of anti-TPO antibodies in the sam- ple leads to reduced binding of radioactivity to the inner surface of the tube. Therefore, the amount of radioactivity measured is reversely proportional to the antibody concentration of the tested sample. After the incubation period, the amount of human TPO and iodine-125 labelled anti-TPO antibody (tracer) not bound to the tube is removed by aspirating or decanting the liquid phase. The radioactivity remaining in the tube is measured. For anti-TPO antibodies there exists no international standard with official status.
Info ALPCO DiagnosticsCall ALPCO Diagnostics to buy products (US and Canada only; other locations use number below) USACanada1-866-466-7731

Customer Service: (800) 592-5726
Web site: http://www.alpco.com

Related medicine products :

1. Free T3 EIA Thyroid Function 025-BC-1006
2. Free T4 EIA Thyroid Function 025-BC-1008
3. TG (Ab) EIA Thyroid Function 012-MDKAT-1 Thyroglobulin anti-tg
4. Total T4 EIA Thyroid Function 025-BC-1007
5. TPO (Ab) EIA Thyroid Function 012-MDKAM-1 Thyroid Peroxidase
6. TG (Ab) RIA Thyroid Function 014-HD 27.1 Thyroglobulin
7. Total T3 EIA Thyroid Function 025-BC-1005
8. TSH EIA Thyroid Function 025-BC-1001
9. Ultrasensitive TSH EIA Thyroid Function 025-BC-1003
10. MSTS-1 Thyroid Shield
11. Standard Thyroid
BD Directigen RSV Test fast, easy and accurate, its truly STAT. And it will help your laboratory quickly and confidently support critical antiviral therapy recommendations....
Anti-Rotavirus Antigen Assay (ELISA)....
Qualitative ELISA for the detection of rotavirus antigen....
Latex agglutination slide test for the qualitative detection of rotavirus from fecal specimens....
Medicine Products:
(Date:5/6/2016)... ... May 06, 2016 , ... In ... career-focused education and corporate training, and the National Military Family Association, a nonprofit ... Aquino as the second full-tuition scholarship recipient of 2016. , “Being awarded ...
(Date:5/6/2016)... ... May 06, 2016 , ... “ Crossing Over: Affirmations of Faith in ... patients who have allowed those holding vigil to glimpse into the supernatural as their ... to help readers spiritually and practically gain insight into providing care to terminal patients. ...
(Date:5/5/2016)... ... ... While the practice and profession of Aging Life Care is not new, there ... and resources. Aging Life Care plays an important role as these professionals are prepared ... Care is a holistic, client-centered approach to caring for older adults or others facing ...
(Date:5/5/2016)... ... , ... Textile Exchange is excited to announce the release of ... stakeholder review is an important opportunity for interested parties to give input into the ... wool industry., The RWS is intended to be a global benchmark for animal welfare ...
(Date:5/5/2016)... , ... May 05, 2016 , ... ... to offer patients with non-valvular atrial fibrillation (A-Fib) an alternative to long-term warfarin ... first offering the procedure in April of 2015, Florida Hospital Pepin Heart Institute ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... ZIONA, Israel , May 4, ... TASE: BVXV) announced today that BiondVax,s CEO, Dr. Ron ... conference in New York City . ... at 10:30am at Pioneers 2016, a conference presented by ... York Palace Hotel. The BiondVax presentation that Dr. ...
(Date:5/4/2016)... May 4, 2016 Yissum ... announced today that it had signed an exclusive ... , developer of novel protein degradation and immunomodulatory drugs ... commercialization of drug candidates representing first-in-class therapy for hematologic ... not disclosed. The novel technology was developed ...
(Date:5/4/2016)... , May 4, 2016 ... completion of an alternative public offering (APO). This was ... operating company, Valeritas, Inc. and a private placement of ... at $5.00 per share. Under the terms ... 3, 2016, Valeritas Holdings, Inc. will trade on the ...
Breaking Medicine Technology: